<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6663013\results\search\disease\results.xml">
  <result pre="Life Sciences : Genetics: Microbial Genetics Severe cases of seasonal" exact="influenza" post="in Russia in 2017-2018 Severe cases of seasonal influenza"/>
  <result pre="seasonal influenza in Russia in 2017-2018 Severe cases of seasonal" exact="influenza" post="in Russia in 2017-2018 http://orcid.org/0000-0001-8865-8592KolosovaNatalia P.ConceptualizationFormal analysisInvestigationMethodologyValidationVisualizationWriting – original"/>
  <result pre="the original author and source are credited.pone.0220401.pdf Abstract The 2017–2018" exact="influenza" post="epidemic season in Russia was characterized by a relatively"/>
  <result pre="and mortality. We evaluated herd immunity prior to the 2017–2018" exact="influenza" post="season in hemagglutination inhibition assay, and performed characterization of"/>
  <result pre="influenza season in hemagglutination inhibition assay, and performed characterization of" exact="influenza" post="viruses isolated from severe or fatal influenza cases and"/>
  <result pre="performed characterization of influenza viruses isolated from severe or fatal" exact="influenza" post="cases and from influenza cases in people vaccinated in"/>
  <result pre="viruses isolated from severe or fatal influenza cases and from" exact="influenza" post="cases in people vaccinated in the fall of 2017."/>
  <result pre="the fall of 2017. During the 2017–2018 epidemic season, 87" exact="influenza" post="A and B viruses were isolated and viruses of"/>
  <result pre="and B viruses were isolated and viruses of the 75" exact="influenza" post="cases, including selected viral isolates and viruses analyzed directly"/>
  <result pre="hemagglutinin gene of A(H1N1)pdm09 for epidemiological surveillance. One strain of" exact="influenza" post="virus A(H1N1)pdm09 was resistant to oseltamivir and had the"/>
  <result pre="the presence of protective antibody titers against vaccine strains of" exact="influenza" post="A and influenza B/Victoria-like, respectively. Mass vaccination of the"/>
  <result pre="protective antibody titers against vaccine strains of influenza A and" exact="influenza" post="B/Victoria-like, respectively. Mass vaccination of the population had evidently"/>
  <result pre="reduced the severity of the flu epidemic during the 2017–2018" exact="influenza" post="epidemic season in Russia. Funding This work was supported"/>
  <result pre="and its Supporting Information files. Introduction Influenza is an infectious" exact="respiratory disease" post="caused by influenza viruses type A, B, C and"/>
  <result pre="files. Introduction Influenza is an infectious respiratory disease caused by" exact="influenza" post="viruses type A, B, C and D. The disease"/>
  <result pre="An emergence in the human population of a variant of" exact="influenza" post="A virus with new antigenic properties may cause a"/>
  <result pre="mortality [3]. Thereby, monitoring population immunity and severe cases of" exact="influenza" post="is an essential activity carried out within the framework"/>
  <result pre="studying the population humoral immunity and the epidemic situation of" exact="influenza" post="in Russia since 2009 [4–8]. This study continues our"/>
  <result pre="continues our work on annual evaluation of herd immunity to" exact="influenza" post="just before the influenza epidemic seasons in Russia and"/>
  <result pre="annual evaluation of herd immunity to influenza just before the" exact="influenza" post="epidemic seasons in Russia and analyses of circulating influenza"/>
  <result pre="the influenza epidemic seasons in Russia and analyses of circulating" exact="influenza" post="viruses in Russia, with a focus on the influenza"/>
  <result pre="circulating influenza viruses in Russia, with a focus on the" exact="influenza" post="viruses which cause severe illness, including cases with lethal"/>
  <result pre="with lethal outcome. The epidemic rise in the incidence of" exact="influenza" post="in Russia began during the 6th to 7th weeks"/>
  <result pre="In contrast to Western countries, the epidemic rise in the" exact="influenza" post="disease incidence was smooth, and throughout the epidemic, the"/>
  <result pre="2017–2018 epidemic season in Russia was characterized by a low" exact="influenza" post="disease incidence in persons vaccinated in the fall of"/>
  <result pre="purpose of this study was to assess population immunity to" exact="influenza" post="viruses before the 2017–2018 Russian epidemic season and to"/>
  <result pre="viruses before the 2017–2018 Russian epidemic season and to characterize" exact="influenza" post="viruses from clinical material from cases of severe influenza"/>
  <result pre="characterize influenza viruses from clinical material from cases of severe" exact="influenza" post="disease, autopsy material from influenza disease cases with lethal"/>
  <result pre="material from cases of severe influenza disease, autopsy material from" exact="influenza" post="disease cases with lethal outcome, and clinical material from"/>
  <result pre="[6]. The A/Michigan/45/2015 A(H1N1)pdm09, A/HongKong/4801/2014 A(H3N2) and B/Brisbane/60/2008 (Victoria lineage)" exact="influenza" post="viruses were kindly provided by the WHO Collaborating Center"/>
  <result pre="the Russian Federation. PCR-based diagnostics of the original material for" exact="influenza" post="virus RNA was conducted in local laboratories, and then"/>
  <result pre="of cells [12]. Diagnostic real-time PCR for detecting RNA of" exact="influenza" post="A virus and influenza B virus was performed using"/>
  <result pre="real-time PCR for detecting RNA of influenza A virus and" exact="influenza" post="B virus was performed using RNA isolated with the"/>
  <result pre="Rights Protection and Human Wellbeing (Moscow, Russia). Serological analysis of" exact="influenza" post="viruses Serological typing/subtyping of isolated influenza virus strains and"/>
  <result pre="Russia). Serological analysis of influenza viruses Serological typing/subtyping of isolated" exact="influenza" post="virus strains and studying their antigenic features were carried"/>
  <result pre="A/Michigan/45/2015 A(H1N1)pdm09, A/HongKong/4801/2014 A(H3N2), B/Brisbane/60/2008 (Victoria lineage), B/Phuket/3073/2013 (Yamagata lineage)" exact="influenza" post="viruses were used for serological typing of influenza virus"/>
  <result pre="(Yamagata lineage) influenza viruses were used for serological typing of" exact="influenza" post="virus isolates. All reference sera were kindly furnished by"/>
  <result pre="Influenza in Atlanta, US. Sensitivity to anti-neuraminidase drugs Susceptibility of" exact="influenza" post="viruses to neuraminidase inhibitors oseltamivir and zanamivir was tested"/>
  <result pre="the protocol recommended by the WHO [13]. Sequence analysis of" exact="influenza" post="viruses Sequencing was carried out at the FBRI SRC"/>
  <result pre="Results Investigation of herd immunity To assess herd immunity to" exact="influenza" post="A and B viruses, 3728 serum samples collected in"/>
  <result pre="the results obtained in the HI tests with the seasonal" exact="influenza" post="vaccine strains for 2017–2018. Fig 1 Seropositivity for influenza"/>
  <result pre="seasonal influenza vaccine strains for 2017–2018. Fig 1 Seropositivity for" exact="influenza" post="vaccine viruses in the studied groups of people from"/>
  <result pre="(1:40 and above) in HI tests with vaccine strains of" exact="influenza" post="A virus subtypes A(H1N1)pdm09 and A(H3N2) (Fig 1). The"/>
  <result pre="A(H3N2) (Fig 1). The proportion of seropositive individuals for the" exact="influenza" post="B virus of the Victoria genetic lineage was slightly"/>
  <result pre="seropositive individuals in 2016, versus 33% in 2017) to the" exact="influenza" post="A(H1N1)pdm09 virus, while the proportion of seropositive individuals to"/>
  <result pre="strains in circulation during the 2016–2017 season. Characterization of seasonal" exact="influenza" post="viruses In the epidemic season of 2017–2018, the SRC"/>
  <result pre="primary samples were received that were positive for RNA of" exact="influenza" post="A and B viruses, including 90 samples of autopsy"/>
  <result pre="with severe disease and 136 samples from patients vaccinated against" exact="influenza" post="in the fall of 2017 (Table 1). 10.1371/journal.pone.0220401.t001Table 1"/>
  <result pre="1). 10.1371/journal.pone.0220401.t001Table 1 Data on patients with cases of severe" exact="influenza" post="disease, cases of influenza disease with fatal outcome, and"/>
  <result pre="on patients with cases of severe influenza disease, cases of" exact="influenza" post="disease with fatal outcome, and patients vaccinated in the"/>
  <result pre="2017. Group Fatal cases (number) Severe cases (number) Vaccinated against" exact="influenza" post="in the fall of 2017 (number of infected) Sex"/>
  <result pre="70 3 Pregnant women 1 146 12 People vaccinated against" exact="influenza" post="in the fall of 2017 4 132 136 Total"/>
  <result pre="136 Total 90 757 136 During the monitoring of seasonal" exact="influenza" post="virus in the territory of the Russian Federation in"/>
  <result pre="Russian Federation in the 2017–2018 epidemic season, 87 strains of" exact="influenza" post="A and B viruses were isolated: 47 strains of"/>
  <result pre="strains of A(H1N1)pdm09, 13 strains of A(H3N2), 25 strains of" exact="influenza" post="B virus of the Yamagata lineage and 2 strains"/>
  <result pre="B virus of the Yamagata lineage and 2 strains of" exact="influenza" post="B virus of the Victoria lineage. Influenza viruses from"/>
  <result pre="clinical material (S1, S3 and S5 Tables). Antigenic analysis of" exact="influenza" post="viruses The antigenic properties of all strains of influenza"/>
  <result pre="of influenza viruses The antigenic properties of all strains of" exact="influenza" post="A(H1N1)pdm09 virus (including 17 isolates from lethal cases of"/>
  <result pre="disease) were similar to the A/Michigan/45/2015 vaccine strain, strains of" exact="influenza" post="B/Yamagata-like virus (3 of which were isolated from lethal"/>
  <result pre="similar to the B/Phuket/3073/2013 vaccine strain, and two strains of" exact="influenza" post="B/Victoria-like virus were similar to the B/Brisbane/60/2008 vaccine strain."/>
  <result pre="egg adaptive changes decreased vaccine effectiveness [19]. Genetic analysis of" exact="influenza" post="viruses Influenza viruses from 75 selected cases (original specimen"/>
  <result pre="(S1 Table), 26 viruses of A(H3N2) subtype (S3 Table), 18" exact="influenza" post="B/Yamagata-like viruses and 2 influenza B/Victoria-like viruses (S5 Table)."/>
  <result pre="A(H3N2) subtype (S3 Table), 18 influenza B/Yamagata-like viruses and 2" exact="influenza" post="B/Victoria-like viruses (S5 Table). The complete nucleotide sequences of"/>
  <result pre="complete nucleotide sequences of the hemagglutinin (HA) gene for 70" exact="influenza" post="viruses were determined and were used to perform a"/>
  <result pre="analysis. The results of the phylogenetic analysis showed that the" exact="influenza" post="A(H1N1)pdm09 viruses from 26 cases grouped in clade 6B.1"/>
  <result pre="from 26 cases grouped in clade 6B.1 (S1 Fig), 25" exact="influenza" post="A(H3N2) viruses grouped in clade 3C.2a (of which 11"/>
  <result pre="of complete genomes (or partially sequenced genomes) of 29 selected" exact="influenza" post="viruses A(H1N1)pdm09 showed a close genetic similarity with the"/>
  <result pre="A(H1N1)pdm09 cases comprised 65% of all studied and diagnostically confirmed" exact="influenza" post="lethal cases in Russia, with H3N2 and influenza type"/>
  <result pre="diagnostically confirmed influenza lethal cases in Russia, with H3N2 and" exact="influenza" post="type B being 15% and 20%, respectively, according to"/>
  <result pre="of the HA gene of 29 selected cases of A(H1N1)pdm09" exact="influenza" post="revealed in the major virus variant the presence of"/>
  <result pre="criteria of the WHO expert working group on surveillance of" exact="influenza" post="antiviral susceptibility) [20, 21]. No mutations associated with resistance"/>
  <result pre="antiviral susceptibility) [20, 21]. No mutations associated with resistance of" exact="influenza" post="A(H1N1)pdm09 viruses to the NA inhibitor zanamivir were identified."/>
  <result pre="the NA inhibitor zanamivir were identified. Genetic analysis of A(H3N2)" exact="influenza" post="virus was performed for 26 selected cases, including 2"/>
  <result pre="of amino acid substitutions in the HA of the studied" exact="influenza" post="A(H3N2) viruses in comparison with the A/Hong Kong/4801/2014 vaccine"/>
  <result pre="with the vaccine strain. The majority of the fatal of" exact="influenza" post="B/Yamagata-like viruses were associated with the presence of the"/>
  <result pre="influenza B/Yamagata-like viruses were associated with the presence of the" exact="influenza" post="illness risk group factors established by the WHO (age"/>
  <result pre="genetically similar to the B/Brisbane/60/2008 vaccine strain. No variants of" exact="influenza" post="B/Victoria-like viruses with a deletion in the HA gene"/>
  <result pre="amino acid positions in the protein) were found. Analysis of" exact="influenza" post="cases in vaccinated individuals Of the 136 cases in"/>
  <result pre="those that recovered from influenza, 63 cases were diagnosed with" exact="influenza" post="virus B, 41 with A(H3N2) virus, 25 with A(H1N1)pdm09"/>
  <result pre="with A(H3N2) virus, 25 with A(H1N1)pdm09 virus and 3 with" exact="influenza" post="A virus that was not subtyped. There were only"/>
  <result pre="B/Yamagata-like virus. One of the A(H1N1)pdm09 viruses from a lethal" exact="influenza" post="case in a vaccinated individual, A/Irkutsk/1727/2018, was genetically analyzed."/>
  <result pre="the presence of serious chronic diseases, which are considered as" exact="influenza" post="risk factors by the WHO [26]. The second lethal"/>
  <result pre="risk factors by the WHO [26]. The second lethal A(H1N1)pdm09" exact="influenza" post="case in a vaccinated individual was associated with the"/>
  <result pre="the presence of serious chronic diseases, one of which was" exact="chronic obstructive pulmonary disease" post="(COPD). Analysis of sensitivity to anti-neuraminidase drugs In the"/>
  <result pre="seasonal influenza, sensitivity to oseltamivir and zanamivir of 87 isolated" exact="influenza" post="viruses A and B was analyzed. According to the"/>
  <result pre="the phenotypic study, all isolated isolates of A(H3N2) and B" exact="influenza" post="viruses were sensitive to anti-neuraminidase drugs oseltamivir and zanamivir."/>
  <result pre="Discussion In this study the assessment of population immunity to" exact="influenza" post="viruses before the 2017–2018 Russian epidemic season was performed"/>
  <result pre="Russian epidemic season was performed and a representative set of" exact="influenza" post="viruses, which circulated in Russia during the 2017–2018 epidemic"/>
  <result pre="Russia during the 2017–2018 epidemic season, from cases of severe" exact="influenza" post="disease, including cases with lethal outcome, and clinical material"/>
  <result pre="at the beginning of the epidemic period, one of the" exact="influenza" post="A virus subtypes (A(H1N1)pdm09 and A(H3N2), respectively) prevailed in"/>
  <result pre="(A(H1N1)pdm09 and A(H3N2), respectively) prevailed in the northern hemisphere and" exact="influenza" post="B viruses became prevalent at the end of the"/>
  <result pre="the epidemic season, joint circulation of type A and B" exact="influenza" post="strains was observed [6, 8]. The United States were"/>
  <result pre="The United States were characterized by a significant prevalence of" exact="influenza" post="A viruses (71.2%) over influenza B viruses (28.8%); of"/>
  <result pre="by a significant prevalence of influenza A viruses (71.2%) over" exact="influenza" post="B viruses (28.8%); of the influenza A viruses, 84.9%"/>
  <result pre="A viruses (71.2%) over influenza B viruses (28.8%); of the" exact="influenza" post="A viruses, 84.9% belonged to the A(H3N2) subtype and"/>
  <result pre="A(H3N2) subtype and 15.1% belonged to the A(H1N1)pdm09 subtype. Among" exact="influenza" post="B viruses, viruses of the B/Yamagata genetic lineage prevailed"/>
  <result pre="was observed with occurrences of a slightly higher prevalence of" exact="influenza" post="A virus (Canada, 57%), or influenza B virus (Europe,"/>
  <result pre="slightly higher prevalence of influenza A virus (Canada, 57%), or" exact="influenza" post="B virus (Europe, 56%). Different countries in Europe demonstrated"/>
  <result pre="in Europe demonstrated the predominance of a particular subtype of" exact="influenza" post="A virus (A(H3N2) in the UK, A(H1N1)pdm09 in France,"/>
  <result pre="proportions of both subtypes were approximately equal [9]. In China," exact="influenza" post="viruses of A and B type circulated in approximately"/>
  <result pre="to 4th weeks of 2018), A(H1N1)pdm09 strains significantly prevailed among" exact="influenza" post="A viruses [4TN]. Most of the influenza A(H1N1)pdm09 viruses"/>
  <result pre="significantly prevailed among influenza A viruses [4TN]. Most of the" exact="influenza" post="A(H1N1)pdm09 viruses studied in North America and Europe were"/>
  <result pre="recommendation of the WHO [29]. In Russia, none of the" exact="influenza" post="virus subtypes was dominant in the 2017–2018 epidemic season:"/>
  <result pre="27]. Analysis revealed an increase in the proportion of A(H1N1)pdm09" exact="influenza" post="virus detected in lethal influenza cases (65%) compared to"/>
  <result pre="in the proportion of A(H1N1)pdm09 influenza virus detected in lethal" exact="influenza" post="cases (65%) compared to equal proportions of A(H1N1)pdm09, A(H3N2)"/>
  <result pre="cases (65%) compared to equal proportions of A(H1N1)pdm09, A(H3N2) and" exact="influenza" post="B viruses in all influenza cases. A similar increased"/>
  <result pre="proportions of A(H1N1)pdm09, A(H3N2) and influenza B viruses in all" exact="influenza" post="cases. A similar increased proportion of A(H1N1)pdm09 compared with"/>
  <result pre="virus isolates from the 19 studied lethal cases of A(H1N1)pdm09" exact="influenza" post="(Table 2, S1 and S2 Tables). It is known"/>
  <result pre="tract, which can lead to an increased risk of developing" exact="viral pneumonia." post="Some researchers suggest that increased virulence and lethality of"/>
  <result pre="Some researchers suggest that increased virulence and lethality of A(H1N1)pdm09" exact="influenza" post="virus may be caused by the presence of D222G/N"/>
  <result pre="accumulate as a result of selection from a mixture of" exact="influenza" post="virus variants (quasi-species) in the lower parts of the"/>
  <result pre="receptors in allantoic cells [35, 36, 37]. Cultivation of human" exact="influenza" post="viruses on MDCK cells has proved to be a"/>
  <result pre="stability and are used as the standard cell line for" exact="influenza" post="virus propagation [34]. MDCK cells have both 2,6- and"/>
  <result pre="those cell types. In previously reported genetic stability studies of" exact="influenza" post="virus propagation on MDCK cells, it was shown that"/>
  <result pre="evaluate the significance of the observed genetic changes of seasonal" exact="influenza" post="viruses in studies that employ virus isolation using MDCK"/>
  <result pre="epidemiological analysis and prognosis. Among the 87 analyzed isolates of" exact="influenza" post="A and B viruses, only one A(H1N1)pdm09 strain isolated"/>
  <result pre="only one A(H1N1)pdm09 strain isolated from a lethal case of" exact="influenza" post="was resistant to oseltamivir while remaining susceptible to zanamivir;"/>
  <result pre="season of 2017–2018, however, no more than 1% of the" exact="influenza" post="viruses analyzed in the Northern Hemisphere were characterized by"/>
  <result pre="decrease in sensitivity to NA inhibitors [27]. This class of" exact="influenza" post="drugs is still highly effective and specific for the"/>
  <result pre="is still highly effective and specific for the treatment of" exact="influenza" post="and is recommended for use at an early stage"/>
  <result pre="the population with protective antibody titers was 24%-47% against the" exact="influenza" post="vaccine strains prior to the 2017–2018 epidemic season and"/>
  <result pre="VB &quot;Vector�?, Rospotrebnadzor received clinical samples from 136 cases of" exact="influenza" post="among individuals vaccinated in the fall of 2017, 60%"/>
  <result pre="the fall of 2017, 60% of which included cases of" exact="influenza" post="disease among children under the age of 18 years"/>
  <result pre="the 2017–2018 season. The epidemic rise in the incidence of" exact="influenza" post="began during the 6th to 7th weeks of 2018,"/>
  <result pre="The proportion of patients with severe acute respiratory infection of" exact="influenza" post="etiology placed in the intensive care unit (2.3%) was"/>
  <result pre="trivalent vaccine recommended by the WHO for use in the" exact="influenza" post="season of 2018–2019, 2 components were simultaneously replaced: A(H3N2)"/>
  <result pre="instead of B/Brisbane/60/2008 strain) [27]. A new variant of B/Victoria-like" exact="influenza" post="virus, which has a deletion in the HA gene,"/>
  <result pre="prior to the 2017–2018 epidemic season. The rise of the" exact="influenza" post="epidemic began during the 6th to 7th weeks of"/>
  <result pre="2017–2018 epidemic season in Russia was characterized by a low" exact="influenza" post="disease incidence in persons vaccinated in the fall of"/>
  <result pre="next generation sequencing of the original clinical material and isolated" exact="influenza" post="strains of A(H1N1)pdm09 viruses revealed major or minor viral"/>
  <result pre="the 87 analyzed viral isolates only one strain of A(H1N1)pdm09" exact="influenza" post="virus was resistant to oseltamivir and had the H275Y"/>
  <result pre="inhibitor drugs at the first manifestation of clinical signs of" exact="influenza" post="disease are effective means of population protection against influenza."/>
  <result pre="information S1 Fig The phylogenetic tree for HA of A(H1N1)pdm09" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
  <result pre="file. S2 Fig The phylogenetic tree for HA of A(H3N2)" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
  <result pre="file. S3 Fig The phylogenetic tree for HA of B/Yamagata-like" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
  <result pre="file. S4 Fig The phylogenetic tree for HA of B/Victoria-like" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
  <result pre="Click here for additional data file. S5 Table Type B" exact="influenza" post="virus cases characteristics. (DOC) LINK Click here for additional"/>
  <result pre="additional data file. S6 Table Case characteristics and properties of" exact="influenza" post="viruses isolated and characterized in the 2017–2018 epidemic season."/>
  <result pre="10.1016/j.meegid.2011.05.00221600305 5IlyichevaT, SobolevI, SusloparovI, KurskayaO, DurymanovA, SharshovK, et al.Monitoring of" exact="influenza" post="viruses in Western Siberia in 2008–2012. Infection, Genetics and"/>
  <result pre="KolosovaN, GoncharovaN, SvyatchenkoS, PetrovaO, BondarA, MikheevV, RyzhikovAFatal cases of seasonal" exact="influenza" post="in Russia in 2015–2016. PLoS One2016; 11(10):e016533210.1371/journal.pone.016533227776172 7IlyichevaT, AbdurashitovM,"/>
  <result pre="GoncharovaN, KolosovaN, MikheevV, RyzhikovA. Herd immunity and fatal cases of" exact="influenza" post="among the population exposed to poultry and wild birds"/>
  <result pre="2016; 88(1):35–44. 10.1002/jmv.2430126105790 8IlyichevaTN., DurymanovAG., SvyatchenkoSV, et al.Humoral immunity to" exact="influenza" post="in an at-risk population and severe influenza cases in"/>
  <result pre="al.Humoral immunity to influenza in an at-risk population and severe" exact="influenza" post="cases in Russia in 2016–2017. Arch Virol. 2018; 163:"/>
  <result pre="from http://www.influenza.spb.ru/en/influenza_surveillance_system_in_russia/who_national_influenza_centre. 11MarchenkoVY, SusloparovIM, KomissarovAB, et al.Reintroduction of highly pathogenic" exact="avian influenza" post="A/H5N8 virus of clade 2.3.4.4. in Russia. Arch.Virol. 2017;162(5):1381–1385."/>
  <result pre="http://www.influenza.spb.ru/en/influenza_surveillance_system_in_russia/who_national_influenza_centre. 11MarchenkoVY, SusloparovIM, KomissarovAB, et al.Reintroduction of highly pathogenic avian" exact="influenza" post="A/H5N8 virus of clade 2.3.4.4. in Russia. Arch.Virol. 2017;162(5):1381–1385."/>
  <result pre="method for full genome sequencing of multiple subtypes of human" exact="influenza" post="A viruses. J Clin Virol. 2015;68:43–48. 10.1016/j.jcv.2015.04.01926071334 16HoffmannE, StechJ,"/>
  <result pre="PerezDR. Universal primer set for the full-length amplification of all" exact="influenza" post="A viruses. Arch. Virol. 2001;146:2275–2289. 10.1007/s00705017000211811679 17Li H, 2013."/>
  <result pre="10.1093/molbev/mst19724132122 19BarrIG, DonisRO, KatzJM, McCauleyJW, OdagiriT, TrusheimH, et al.Cell culture-derived" exact="influenza" post="vaccines in the severe 2017–2018 epidemic season: a step"/>
  <result pre="in the severe 2017–2018 epidemic season: a step towards improved" exact="influenza" post="vaccine effectiveness. NPJ Vaccines. 2018109;3:4410.1038/s41541-018-0079-z30323955 20collab: WHOMeetings of the"/>
  <result pre="20collab: WHOMeetings of the WHO working group on surveillance of" exact="influenza" post="antiviral susceptibility—Geneva, November 2011 and June 2012. Wkly. Epidemiol."/>
  <result pre="GregoryV, GubarevaLV, et al.Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors and status of novel antivirals,"/>
  <result pre="HsuSZ, KuoCY, HuangHY, HuangTY, WangHC, et al.An epidemic surge of" exact="influenza" post="A(H3N2) virus at the end of the 2016–2017 season"/>
  <result pre="24ZostSJ, ParkhouseK, GuminaME, KimK, Diaz PerezS, WilsonPC, et al.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
  <result pre="BarrIG. In vitro generation of neuraminidase inhibitor resistance in A(H5N1)" exact="influenza" post="viruses. Antimicrob Agents Chemother. 2009;53(10):4433–4440. 10.1128/AAC.00334-0919651908 26Geneva: World Health"/>
  <result pre="Mortal Wkly Rep. 201868;67(22):634–642. 10.15585/mmwr.mm6722a429879098 28BlantonL, AlabiN, MustaquimD, et al.Update:" exact="influenza" post="activity in the United States during the 2016–17 season"/>
  <result pre="States during the 2016–17 season and composition of the 2017–18" exact="influenza" post="vaccine. MMWR Morb Mortal Wkly Rep2017;66:668–76. 10.15585/mmwr.mm6625a328662019 29BlumbergEAMMWR: Prevention"/>
  <result pre="Am J Transplant. 201811;18(11):282910.1111/ajt.1514030372600 30SelkovaEP, GrenkovaTA, GudovaNV, OganesyanAS. Results on" exact="influenza" post="and acute respiratory viral infection in the 2017–2018 epidemic"/>
  <result pre="SnackenR, MelidouA, IonescuS, PenttinenP. The European Influenza Surveillance Network. Dominant" exact="influenza" post="A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and"/>
  <result pre="GiombiniE, BartoliniB, AbbateI, et al.Detection of haemagglutinin D222 polymorphisms in" exact="influenza" post="A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. Clin Microbiol Infect. 2013;19(7):668–73."/>
  <result pre="33BaldantiF, CampaniniG, PirallaA, RovidaF, BraschiA, MojoliF, et al.Severe outcome of" exact="influenza" post="A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin:"/>
  <result pre="LaurieKL. MDCK-SIAT1 cells show improved isolation rates for recent human" exact="influenza" post="viruses compared to conventional MDCK cells. J Clin Microbiol."/>
  <result pre="linkages in the chicken egg amnion and allantois influence human" exact="influenza" post="virus receptor specificity and variant selection. J. Virol. 71:3357–3362."/>
  <result pre="JiaLiu, ZiLi, YuelongShu, DayanWang. Mutations associated with egg adaptation of" exact="influenza" post="A(H1N1)pdm09 virus in laboratory based surveillance in China, 2009–2016,"/>
  <result pre="MajorD, RobertsonEW, WoodJM. Sequence analysis of the haemagglutinin (HA) of" exact="influenza" post="A (H1N1) viruses present in clinical material and comparison"/>
  <result pre="J Gen Virol. 1991;72:2671–77; 10.1099/0022-1317-72-11-2671 .1940864 38ChowellG, MillerMA, ViboudC. Seasonal" exact="influenza" post="in the United States, France, and Australia: transmission and"/>
  <result pre="inhibition antibody titers as a correlate of protection for inactivated" exact="influenza" post="vaccines in children. Pediatr Infect Dis J. 201112;30(12):1081–5. 10.1097/INF.0b013e318236766221983214"/>
 </snippets>
</snippetsTree>
